Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 3 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3 Breast Neoplasms 3 Stomatitis 2 Neoplasms 2 Mucositis 2 Vulvodynia 1 Urologic Neoplasms 1 Urologic Diseases 1 Urolithiasis 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Skin Neoplasms 1 Pain, Postoperative 1 Pain 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Mobility Limitation 1 MRSA Colonization 1 Lymphoma 1 Leukemia 1 Ilues 1 Hydronephrosis 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Dyspareunia 1 Disease 1

Interventions

Fentanyl 19 Analgesia 15 Acupuncture Therapy 13 Oxycodone 12 Zoledronic Acid 11 Surveys and Questionnaires 10 nabiximols 9 Therapeutics 9 Morphine 9 Acetaminophen 9 Psychiatric Rehabilitation 8 Ketamine 8 Hydromorphone 7 Lidocaine 6 Ibandronic Acid 6 Radiotherapy 5 Early Intervention, Educational 5 Bupivacaine 5 Analgesics, Opioid 5 Yoga 4 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Ropivacaine 4 Music Therapy 4 Methadone 4 Massage 4 Aromatherapy 4 alvimopan 3 Tapentadol 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain × Water × Clear all

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡